A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J.
Nat Med. 2005 May;11(5):551-5. Epub 2005 Apr 24.PMID: 15852017 [PubMed - indexed for MEDLINE]Related articles